Open Access
Vet. Res.
Volume 40, Number 6, November-December 2009
Number of page(s) 14
Published online 24 June 2009
How to cite this article Vet. Res. (2009) 40:54
References of  Vet. Res. (2009) 40:54
  1. Addison E.G., North J., Bakhsh I., Marden C., Haq S., Al-Sarraj S., et al., Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity, Immunology (2005) 116:354–361 [CrossRef] [PubMed].
  2. Adkins B., Leclerc C., Marshall-Clarke S., Neonatal adaptive immunity comes of age, Nat. Rev. Immunol. (2004) 4:553–564 [CrossRef] [PubMed].
  3. Altman D.G., Statistics in medical journals: developments in the 1980s, Stat. Med. (1991) 10:1897–1913 [CrossRef] [PubMed].
  4. Bastos R.G., Johnson W.C., Mwangi W., Brown W.C., Goff W.L., Bovine NK cells acquire cytotoxic activity and produce IFN-gamma after stimulation by Mycobacterium bovis BCG- or Babesia bovis-exposed splenic dendritic cells, Vet. Immunol. Immunopathol. (2008) 124:302–312 [CrossRef] [PubMed].
  5. Becknell B., Caligiuri M.A., Interleukin-2, interleukin-15, and their roles in human natural killer cells, Adv. Immunol. (2005) 86:209–239 [PubMed].
  6. Biassoni R., Pessino A., Bottino C., Pende D., Moretta L., Moretta A., The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity, Eur. J. Immunol. (1999) 29:1014–1020 [CrossRef] [PubMed].
  7. Boysen P., Klevar S., Olsen I., Storset A.K., The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts, Infect. Immun. (2006) 74:953–960 [CrossRef] [PubMed].
  8. Boysen P., Olsen I., Berg I., Kulberg S., Johansen G.M., Storset A.K., Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status, BMC Immunol. (2006) 7:10 [CrossRef] [PubMed].
  9. Boysen P., Gunnes G., Pende D., Valheim M., Storset A.K., Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties, Dev. Comp. Immunol. (2008) 32:773–783 [CrossRef] [PubMed].
  10. Boysen P., Storset A.K., Bovine natural killer cells, Vet. Immunol. Immunopathol. (2009) 130:163–177 [CrossRef] [PubMed].
  11. Butler J.E., Sinkora M., Wertz N., Holtmeier W., Lemke C.D., Development of the neonatal B and T cell repertoire in swine: implications for comparative and veterinary immunology, Vet. Res. (2006) 37:417–441 [CrossRef] [PubMed] [EDP Sciences].
  12. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., et al., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J. Exp. Med. (1994) 180:1395–1403 [CrossRef] [PubMed].
  13. Chen Y.M., Ting C.C., Peng J.W., Yang W.K., Yang K.Y., Tsai C.M., Perng R.P., Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2, J. Interferon Cytokine Res. (2000) 20:31–39 [CrossRef] [PubMed].
  14. Choi S.S., Chhabra V.S., Nguyen Q.H., Ank B.J., Stiehm E.R., Roberts R.L., Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture, Clin. Diagn. Lab. Immunol. (2004) 11:879–888 [PubMed].
  15. Clausen J., Vergeiner B., Enk M., Petzer A.L., Gastl G., Gunsilius E., Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells, Immunobiology (2003) 207:85–93 [CrossRef] [PubMed].
  16. Comans-Bitter W.M., de Groot R., van den Beemd R., Neijens H.J., Hop W.C., Groeneveld K., et al., Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations, J. Pediatr. (1997) 130:388–393 [CrossRef] [PubMed].
  17. De Maria A., Biassoni R., Fogli M., Rizzi M., Cantoni C., Costa P., et al., Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells, Eur. J. Immunol. (2001) 31:3546–3556 [CrossRef] [PubMed].
  18. De Vries E., de Bruin-Versteeg S., Comans-Bitter W.M., de Groot R., Hop W.C., Boerma G.J., et al., Neonatal blood lymphocyte subpopulations: a different perspective when using absolute counts, Biol. Neonate (2000) 77:230–235 [CrossRef] [PubMed].
  19. Ebert E.C., Interleukin 15 is a potent stimulant of intraepithelial lymphocytes, Gastroenterology (1998) 115:1439–1445 [CrossRef] [PubMed].
  20. Endsley J.J., Endsley M.A., Estes D.M., Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages, J. Leukoc. Biol. (2006) 79:71–79 [CrossRef] [PubMed].
  21. Erkeller-Yuksel F.M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., et al., Age-related changes in human blood lymphocyte subpopulations, J. Pediatr. (1992) 120:216–222 [CrossRef] [PubMed].
  22. Falco M., Cantoni C., Bottino C., Moretta A., Biassoni R., Identification of the rat homologue of the human NKp46 triggering receptor, Immunol. Lett. (1999) 68:411–414 [CrossRef] [PubMed].
  23. Fan Y.Y., Yang B.Y., Wu C.Y., Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells, Immunol. Invest. (2008) 37:79–96 [CrossRef] [PubMed].
  24. Fehniger T.A., Cooper M.A., Caligiuri M.A., Interleukin-2 and interleukin-15: immunotherapy for cancer, Cytokine Growth Factor Rev. (2002) 13:169–183 [CrossRef] [PubMed].
  25. Firth M.A., Shewen P.E., Hodgins D.C., Passive and active components of neonatal innate immune defenses, Anim. Health Res. Rev. (2005) 6:143–158 [CrossRef] [PubMed].
  26. Gaddy J., Broxmeyer H.E., Cord blood CD16 + 56- cells with low lytic activity are possible precursors of mature natural killer cells, Cell. Immunol. (1997) 180:132–142 [CrossRef] [PubMed].
  27. Gerdts V., Mutwiri G.K., Tikoo S.K., Babiuk L.A., Mucosal delivery of vaccines in domestic animals, Vet. Res. (2006) 37:487–510 [CrossRef] [PubMed] [EDP Sciences].
  28. Godoy-Ramirez K., Makitalo B., Thorstensson R., Sandstrom E., Biberfeld G., Gaines H., A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry, Cytometry A (2005) 68:71–80 [PubMed].
  29. Goff W.L., Storset A.K., Johnson W.C., Brown W.C., Bovine splenic NK cells synthesize IFN-gamma in response to IL-12-containing supernatants from Babesia bovis-exposed monocyte cultures, Parasite Immunol. (2006) 28:221–228 [CrossRef] [PubMed].
  30. Hannet I., Erkeller-Yuksel F., Lydyard P.,DeneysV., DeBruyere M., Developmental and maturational changes in human blood lymphocyte subpopulations, Immunol. Today (1992) 13:215–218 [CrossRef] [PubMed].
  31. Hauser M.A., Koob M.D., Roth J.A., Variation of neutrophil function with age in calves, Am. J. Vet. Res. (1986) 47:152–153 [PubMed].
  32. Hope J.C., Sopp P., Howard C.J., NK-like CD8(+) cells in immunologically naive neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG, J. Leukoc. Biol. (2002) 71:184–194 [PubMed].
  33. Hoshina T., Kida K., Ito M., Difference in response of NK cell activity in newborns and adult to IL-2, IL-12 and IL-15, Microbiol. Immunol. (1999) 43:161–166 [PubMed].
  34. Howard C.J., Kwong L.S., Villarreal-Ramos B., Sopp P., Hope J.C., Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG, Clin. Exp. Immunol. (2002) 130:190–195 [CrossRef] [PubMed].
  35. Johnson W.C., Bastos R.G., Davis W.C., Goff W.L., Bovine WC1(–) gammadelta T cells incubated with IL-15 express the natural cytotoxicity receptor CD335 (NKp46) and produce IFN-gamma in response to exogenous IL-12 and IL-18, Dev. Comp. Immunol. (2008) 32:1002–1010 [CrossRef] [PubMed].
  36. Kampen A.H., Olsen I., Tollersrud T., Storset A.K., Lund A., Lymphocyte subpopulations and neutrophil function in calves during the first 6 months of life, Vet. Immunol. Immunopathol. (2006) 113:53–63 [CrossRef] [PubMed].
  37. Klevar S., Kulberg S., Boysen P., Storset A.K., Moldal T., Bjorkman C., Olsen I., Natural killer cells act as early responders in an experimental infection with Neospora caninum in calves, Int. J. Parasitol. (2007) 37:329–339 [CrossRef] [PubMed].
  38. Kohl S., Human neonatal natural killer cell cytotoxicity function, Pediatr. Infect. Dis. J. (1999) 18:635–637 [CrossRef] [PubMed].
  39. Kulberg S., Boysen P., Storset A.K., Reference values for relative numbers of natural killer cells in cattle blood, Dev. Comp. Immunol. (2004) 28:941–948 [CrossRef] [PubMed].
  40. Lanier L.L., NK cell recognition, Annu. Rev. Immunol. (2005) 23:225–274 [CrossRef] [PubMed].
  41. Lee S.M., Suen Y., Qian J., Knoppel E., Cairo M.S., The regulation and biological activity of interleukin 12, Leuk. Lymphoma (1998) 29:427–438 [CrossRef] [PubMed].
  42. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., Wessels M.R., Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848, J. Immunol. (2004) 173:4627–4634 [PubMed].
  43. Levy O., Innate immunity of the newborn: basic mechanisms and clinical correlates, Nat. Rev. Immunol. (2007) 7:379–390 [CrossRef] [PubMed].
  44. Lin S.J., Yang M.H., Chao H.C., Kuo M.L., Huang J.L., Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells, Pediatr. Allergy Immunol. (2000) 11:168–174 [PubMed].
  45. Marks-Konczalik J., Dubois S., Losi J.M., Sabzevari H., Yamada N., Feigenbaum L., et al., IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice, Proc. Natl. Acad. Sci. USA (2000) 97:11445–11450 [CrossRef] [PubMed].
  46. Navarro J.A., Seva J., Caro M.R., Sanchez J., Gomez M.A., Bernabe A., Postnatal development of lymphocyte subpopulations in the intestinal mucosa in goat, Vet. Immunol. Immunopathol. (1997) 55:303–311 [CrossRef] [PubMed].
  47. Nguyen Q.H., Roberts R.L., Ank B.J., Lin S.J., Thomas E.K., Stiehm E.R., Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells, Cell. Immunol. (1998) 185:83–92 [CrossRef] [PubMed].
  48. O'Gorman M.R., Millard D.D., Lowder J.N., Yogev R., Lymphocyte subpopulations in healthy 1–3-day-old infants, Cytometry (1998) 34:235–241 [CrossRef] [PubMed].
  49. Olsen I., Boysen P., Kulberg S., Hope J.C., Jungersen G., Storset A.K., Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70, Infect. Immun. (2005) 73:5628–5635 [CrossRef] [PubMed].
  50. Pasquali P., Fayer R., Zarlenga D., Canals A., Marez T., Gomez Munoz M.T., et al., Recombinant bovine interleukin-12 stimulates a gut immune response but does not provide resistance to Cryptosporidium parvum infection in neonatal calves, Vet. Parasitol. (2006) 135:259–268 [CrossRef] [PubMed].
  51. Satwani P., Ayello J., Ven C., O'Neill A.F., Simpson L.L., Baxi L., Cairo M.S., Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function, Br. J. Haematol. (2005) 130:284–292 [CrossRef] [PubMed].
  52. Satwani P., Morris E., van de Ven C., Cairo M.S., Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity, Biol. Neonate (2005) 88:214–227 [CrossRef] [PubMed].
  53. Siegrist C.A., Neonatal and early life vaccinology, Vaccine (2001) 19:3331–3346 [CrossRef] [PubMed].
  54. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., et al., p46, a novel natural killer cell-specific surface molecule that mediates cell activation, J. Exp. Med. (1997) 186:1129–1136 [CrossRef] [PubMed].
  55. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., et al., NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells, Eur. J. Immunol. (1999) 29:1656–1666 [CrossRef] [PubMed].
  56. Storset A.K., Kulberg S., Berg I., Boysen P., Hope J.C., Dissen E., NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics, Eur. J. Immunol. (2004) 34:669–676 [CrossRef] [PubMed].
  57. Sundstrom Y., Nilsson C., Lilja G., Karre K., Troye-Blomberg M., Berg L., The expression of human natural killer cell receptors in early life, Scand. J. Immunol. (2007) 66:335–344 [CrossRef] [PubMed].
  58. Tourais-Esteves I., Bernardet N., Lacroix-Lamande S., Ferret-Bernard S., Laurent F., Neonatal goats display a stronger TH1-type cytokine response to TLR ligands than adults, Dev. Comp. Immunol. (2008) 32:1231–1241 [CrossRef] [PubMed].
  59. Trinchieri G., Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat. Rev. Immunol. (2003) 3:133–146 [CrossRef] [PubMed].
  60. Valentin H., Groux H., Gelin C., Chretien I., Bernard A., Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2, J. Immunol. (1990) 144:875–882 [PubMed].
  61. Velilla P.A., Rugeles M.T., Chougnet C.A., Defective antigen-presenting cell function in human neonates, Clin. Immunol. (2006) 121:251–259 [CrossRef] [PubMed].
  62. Waldmann T.A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nat. Rev. Immunol. (2006) 6:595–601 [CrossRef] [PubMed].
  63. Walzer T., Blery M., Chaix J., Fuseri N., Chasson L., Robbins S.H., et al., Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46, Proc. Natl. Acad. Sci. USA (2007) 104:3384–3389 [CrossRef] [PubMed].
  64. Warren H.S., Kinnear B.F., Kastelein R.L., Lanier L.L., Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells, J. Immunol. (1996) 156:3254–3259 [PubMed].
  65. Zhang C., Zhang J., Niu J., Zhou Z., Tian Z., Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D, Hum. Immunol. (2008) 69:490–500 [CrossRef] [PubMed].